A Common 9 bp Deletion in the Ataxia-telangiectasia-mutated Gene Is Not Associated with Oral Cancer

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3191-3193

  Spyridonidou, Sofia ^a   Yapijakis, Christos ^a   Nkenke, Emeka ^b   Toyoshima, Takeshi ^b   Vylliotis, Antonis ^a   Serefoglou, Zoe ^a   Neukam, Friedrich W ^b   Patsouris, Efstratios ^a   Vairaktaris, Eleftherios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Ataxia telangiectasia mutated gene; ATM; Deletion; Oncogenesis; Oral cancer

Indexed keywords

ATM PROTEIN; DNA;

ARTICLE; ATM GENE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; GENOMIC INSTABILITY; GERMANY; GREECE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ATAXIA TELANGIECTASIA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; MOUTH NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 68549135067     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McDowell JD: An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin of North Am 39: 277-294, 2006.
2. Weinberg RA: How cancer arises. Sci Am 275: 62-70, 1996.
3. Shiloh Y and Kastan MB: ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 83: 209-254, 2001. (Pubitemid 32959266)
4. Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R and Lavin M: Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14: 1911-1921, 1997.
5. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AM and Jackson SP: Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13: 2707-2716, 1996. (Pubitemid 27046126)
6. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677, 1998. (Pubitemid 28435583)
7. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679, 1998. (Pubitemid 28435584)
8. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, Myers EN and Gollin SM: Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer 12: 288-295, 1995.
9. Uzawa K, Suzuki H, Komiya A, Nakanishi H, Ogawara K, Tanzawa H and Sato K: Evidence for two distinct tumour-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer 67: 510-514, 1996. (Pubitemid 26274107)
10. Lazar AD, Winter MR, Nogueira CP, Larson PS, Finnemore EM, Dolan RW, Fuleihan N, Chakravarti A, Zietman A and Rosenberg CL: Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res 4: 2787-2793, 1998. (Pubitemid 28523506)
11. Vorechovský I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster AD and Yuille MA: Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17: 96-99, 1997. (Pubitemid 27377540)
12. Yuille MA, Coignet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovsky I, Dyer MJ and Catovsky D: ATM is usually rearranged in T-cell prolymphocytic leukaemia [published erratum appears in Oncogene 1998;16:2955]. Oncogene 16: 789-796, 1998.
13. Stoppa-Lyonnet D, Soulier J, Laugé A, Dastot H, Garand R, Sigaux F and Stern MH: Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91: 3920-3926, 1998. (Pubitemid 28225761)
14. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA and Taylor AM: Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353: 26-29, 1999. (Pubitemid 29037699)
15. Luo L, Lu FM, Hart S, Foroni L, Rabbani H, Hammarström L, Yuille MR, Catovsky D, Webster AD and Vorechovsky I: Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL [published erratum appears in Cancer Res 1998;58:3488]. Cancer Res 58: 2293-2297, 1998.
16. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC and Croce CM: ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59: 24-27, 1999. (Pubitemid 29062949)
17. Vorechovský I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM and Hammarström L: ATM mutations in cancer families. Cancer Res 56: 4130-4133, 1996.
18. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
19. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM and Thick JA: Mutations revealed by sequencing the 5′ half of the gene for ataxia telangiectasia. Hum Mol Genet 5: 145-149, 1996. (Pubitemid 26018286)
20. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NG, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y and Bar-Shira A: Predominance of null mutations in ataxia- telangiectasia. Hum Mol Genet 5: 433-439, 1996.
21. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA and Gatti RA: Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59: 40-44, 1996. (Pubitemid 26189726)
22. Wright J, Teraoka S, Onengut S, Tolun A, Gatti RA, Ochs HD and Concannon P: A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am J Hum Genet 59: 839-846, 1996. (Pubitemid 26328080)
23. Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, Wegner RD, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthaler U, Sennefelder H, Brohm M, Weber BH and Schindler D: Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8: 69-79, 1999. (Pubitemid 29039050)
24. Li A and Swift M: Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 9: 170-177, 2000. (Pubitemid 30228487)
25. Lavin MF, Scott S, Gueven N, Kozlov S, Peng C and Chen P: Functional consequences of sequence alterations in the ATM gene. DNA Repair 3(8-9): 1197-1205, 2004. (Pubitemid 38997963)
26. Watters D, Khanna KK, Beamish H, Birrell G, Spring K, Kedar P, Gatei M, Stenzel D, Hobson K, Kozlov S, Zhang N, Farrell A, Ramsay J, Gatti R, Lavin M: Cellular localization of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14: 1911-1921, 1997.
27. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP and Lavin MF: ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20: 398-400, 1998. (Pubitemid 28541643)